Division of Endocrinology, Gerontology, and Metabolism, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.
Division of Endocrinology and Diabetes, Department of Pediatrics, Stanford University School of Medicine, Stanford, California, USA.
Diabet Med. 2024 Dec;41(12):e15423. doi: 10.1111/dme.15423. Epub 2024 Aug 8.
Continuous glucose monitoring (CGM) systems are standard of care for youth with type 1 diabetes with the goal of spending >70% time in range (TIR; 70-180 mg/dL, 3.9-10 mmol/L). We aimed to understand paediatric CGM user experiences with TIR metrics considering recent discussion of shifting to time in tight range (TITR; >50% time between 70 and 140 mg/dL, 3.9 and 7.8 mmol/L).
Semi-structured interviews and focus groups with adolescents with type 1 diabetes and parents of youth with type 1 diabetes focused on experiences with TIR goals and reactions to TITR. Groups and interviews were audio-recorded, transcribed and analysed using content analysis.
Thirty participants (N = 19 parents: age 43.6 ± 5.3 years, 79% female, 47% non-Hispanic White, 20 ± 5 months since child's diagnosis; N = 11 adolescents: age 15.3 ± 2 years, 55% female, 55% non-Hispanic White, 16 ± 3 months since diagnosis) attended. Participants had varying levels of understanding of TIR. Some developed personally preferred glucose ranges. Parents often aimed to surpass 70% TIR. Many described feelings of stress and disappointment when they did not meet a TIR goal. Concerns about TITR included increased stress and burden; risk of hypoglycaemia; and family conflict. Some participants said TITR would not change their daily lives; others said it would improve their diabetes management. Families requested care team support and a clear scientific rationale for TITR.
The wealth of CGM data creates frequent opportunities for assessing diabetes management and carries implications for management burden. Input from people with type 1 diabetes and their families will be critical in considering a shift in glycaemic goals and targets.
连续血糖监测(CGM)系统是 1 型糖尿病青少年的标准治疗方法,其目标是将时间在目标范围内(TIR;70-180mg/dL,3.9-10mmol/L)的时间占比超过 70%。我们旨在了解儿科 CGM 用户对 TIR 指标的体验,考虑到最近关于转向严格时间范围内(TITR;70-140mg/dL 之间的时间占比超过 50%,3.9-7.8mmol/L)的讨论。
对 1 型糖尿病青少年及其 1 型糖尿病青少年的父母进行半结构式访谈和焦点小组讨论,重点关注 TIR 目标的体验以及对 TITR 的反应。使用内容分析法对小组讨论和访谈进行音频记录、转录和分析。
共有 30 名参与者(N=19 名父母:年龄 43.6±5.3 岁,79%为女性,47%为非西班牙裔白人,孩子确诊后 20±5 个月;N=11 名青少年:年龄 15.3±2 岁,55%为女性,55%为非西班牙裔白人,确诊后 16±3 个月)参加了研究。参与者对 TIR 的理解程度各不相同。一些人制定了个人偏好的血糖范围。父母通常希望 TIR 超过 70%。许多人在未达到 TIR 目标时感到压力和失望。对 TITR 的担忧包括增加压力和负担;低血糖风险;以及家庭冲突。一些参与者表示 TITR 不会改变他们的日常生活;其他人则表示 TITR 将改善他们的糖尿病管理。家庭希望获得护理团队的支持,并对 TITR 有明确的科学依据。
CGM 数据的丰富性为评估糖尿病管理提供了频繁的机会,并对管理负担产生了影响。1 型糖尿病患者及其家属的意见将对考虑血糖目标的转变至关重要。